Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of LCTX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−27,121−100.0%Sold outHolders
Q3 202527,121$45.8K<0.1%−13,328−33.0%ReducedHolders
Q2 202540,449$36.7K<0.1%00.0%UnchangedHolders
Q1 202540,449$18.3K<0.1%00.0%UnchangedHolders
Q4 202440,449$20.3K<0.1%00.0%UnchangedHolders
Q3 202440,449$36.6K<0.1%00.0%UnchangedHolders
Q2 202440,449$40.3K<0.1%00.0%UnchangedHolders
Q1 202440,449$59.9K<0.1%00.0%UnchangedHolders
Q4 202340,449$44.1K<0.1%00.0%UnchangedHolders
Q3 202340,449$47.7K<0.1%00.0%UnchangedHolders
Q2 202340,449$57.0K<0.1%00.0%UnchangedHolders
Q1 202340,449$60.7K<0.1%−8,015−16.5%ReducedHolders
Q4 202248,464$56.0K<0.1%00.0%UnchangedHolders
Q3 202248,464$55.0K<0.1%−16,691−25.6%ReducedHolders
Q2 202265,155$103.0K<0.1%−63,528−49.4%ReducedHolders
Q1 2022128,683$198.0K<0.1%00.0%UnchangedHolders
Q4 2021128,683$315.0K<0.1%00.0%UnchangedHolders
Q3 2021128,683$324.0K<0.1%00.0%UnchangedHolders
Q2 2021128,683$367.0K<0.1%00.0%UnchangedHolders
Q1 2021128,683$302.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.